POETIC Trial Management Group and Trialists Selected Research

Estrogens (Estrogen)

1/2019

Genomic Instability and TP53 Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

POETIC Trial Management Group and Trialists Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 12/2019 - 11/2016
1	Neoplasms (Cancer) 01/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019
1	Genomic Instability 01/2019

Drug/Important Bio-Agent (IBA)

4	Aromatase InhibitorsIBA 12/2019 - 11/2016
2	Estrogen ReceptorsIBA 01/2019 - 04/2018
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019

Therapy/Procedure

3	Therapeutics 12/2019 - 11/2016